Cancer Epidemiology, screening, Diagnosis & Prognosis

The Epidemiology of Cancer is the study of the factors affecting Cancer, a way to conclude possible tendencies and causes. The study of Cancer Epidemiology practices Epidemiological Methods to discover the cause of Cancer and to recognize and develop enhanced treatments. This extent of study must cope with difficulties of lead time bias and length time bias. Lead time bias is the theory that primary diagnosis may artificially inflate the survival statistics of a Cancer, without actually improving the natural history of the disease. Length bias is the concept that tender growing, more lethargic Tumors are more likely to be recognised by Screening Tests, but improvements in diagnosing more cases of indolent Cancer may not translate into better patient outcomes after the implementation of Screening Programs.

Most Cancers are originally known either because of the appearance of signs or symptoms or through Screening. Neither of these leads to a Definitive Diagnosis, which comprises the examination of a tissue sample by a pathologist. People with suspected Cancer are observed with medical tests. These generally include Blood Tests, CT Scans, X-rays and Endoscopy.

Screenings can find initial Cancer, when it’s most curable. Cancer Screening aims to identify Cancer before symptoms appear. This may include blood tests, urine tests, other tests, or Medical Imaging. The aids of screening in terms of Cancer Prevention, early detection and subsequent treatment must be weighed beside any harm. Worldwide screening, Population Screening or Mass Screening involves screening everyone, generally within a definite age group. Selective Screening detects people who are known to be at advanced risk of developing Cancer, such as people with a family history of Cancer.

  • Circulating tumor cells (CTCs) towards cancer Diagnosis
  • Microfluidic device for cancer screening
  • Cancer Staging
  • Early detection and diagnosis of Cancer
  • Early detection and diagnosis of Cancer

Related Conference of Cancer Epidemiology, screening, Diagnosis & Prognosis

February 20-21, 2019 |

27th Annual Congress on Cancer Science and Targeted Therapies

San Francisco, USA
February 20-21, 2019

International Meeting on Dermato Oncology

Dallas, USA
February 27-28, 2019

17th International Conference on Cancer Research and Therapy

Courtyard Marriott Seoul Times Square, Seoul, South Korea
March 4-5, 2019

24thAnnual meet on Surgical Oncology

Paris, France
March 07-08, 2019

32nd Euro Congress on Cancer Science & Therapy

Barcelona, Spain
March 20-21, 2019

10th Euro Breast Cancer Summit

| Paris, France
March 20-21, 2019

15 thGLOBAL BIOMARKERS SUMMIT

| Paris, France
April 08-09, 2019

3rd World Congress on Radiology and Oncology

Abu Dhabi, UAE
April 29-30, 2019

33rd Global Experts Meeting on Cancer Science & Therapy

Courtyard Marriott Seoul Times Square, Seoul, South Korea
May 06-07, 2019

International Conference on Frontiers in Lung Cancer

| Radisson Hotel Narita | Tokyo, Japan
May 6-7, 2019

3rd Global Summit on Oncology & Cancer

| Radisson Hotel Narita | Tokyo, Japan
May 09-10, 2019

15th World Congress on Blood Cancer

Amsterdam, Netherlands
May 13-14, 2019

16th Asia Pacific
Oncologists Annual Meeting

Holiday Inn Singapore Atrium, Singapore
July 15-16, 2019

23rd Global Annual Oncologists Meeting

Yokohama, Japan
July 19-20, 2019

Women Oncology & Nursing Care

Atlanta, USA
September 13-14, 2019

31st Experts Meet On Cancer Therapy

| Holiday Inn Singapore Atrium | Singapore
October 10-11, 2019 |

37th World Cancer Conference

Dublin, Ireland
October 14-15, 2019

4th World Conference on Breast and Cervical Cancer

Helsinki, Finland
October 21-22, 2019

4th World Congress on Frontiers in Cancer Research and Therapy

Melbourne, Australia
November 11-12 2019

3rd Cancer Diagnostics & Treatment Conference

Frankfurt, Germany

Cancer Epidemiology, screening, Diagnosis & Prognosis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in